Anavex Life Sciences Corp. (AVXL)
4.96
-0.05
(-1.00%)
USD |
NASDAQ |
Jan 20, 14:36
Anavex Life Sciences Enterprise Value: 345.06M for Jan. 16, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| CorMedix, Inc. | 482.86M |
| Verastem, Inc. | 454.91M |
| Ocugen, Inc. | 528.22M |
| AnaptysBio, Inc. | 1.362B |
| Replimune Group, Inc. | 304.92M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -9.825M |
| Total Expenses (Quarterly) | 9.825M |
| EPS Diluted (Quarterly) | -0.1144 |
| Earnings Yield | -10.97% |
| Normalized Earnings Yield | -10.97 |